Introduction: The wholesale FOXO4 DRI peptide selectively induces apoptosis in senescent cells by disrupting FOXO4-p53 binding, presenting stable, large-purity materials for aging and cancer exploration. day-to-day laboratory workflows usually expose a persistent problem: the sluggish and inefficient removing of senescent cells that impair tissue